key: cord-0262019-5x52cdf6
authors: Ganesh, A.; Stang, J. M.; McAlister, F.; Shlakhter, O.; Holodinsky, J. K.; Mann, B.; Hill, M. D.; Smith, E. E.
title: Changes in ischemic stroke presentations and associated workflow during the first wave of the COVID-19 pandemic: A population study in Alberta, Canada
date: 2021-10-07
journal: nan
DOI: 10.1101/2021.10.04.21264529
sha: 92bbaa64a4eed871c717a36e7a7d9fe36a29877d
doc_id: 262019
cord_uid: 5x52cdf6

Background: Pandemics may promote hospital avoidance among patients with emergencies, and added precautions may exacerbate treatment delays. There is a paucity of population-based data on these phenomena for stroke. We examined the effect of the COVID-19 pandemic on the presentation and treatment of ischemic stroke in an entire population. Methods: We used linked provincial administrative data and data from the Quality Improvement and Clinical Research Alberta Stroke Program, a registry capturing stroke-related data on the entire population of Alberta(4.3 million), to identify all patients presenting with stroke in the pre-pandemic(1-January-2016 to 27-February-2020, n=19,531) and pandemic(28-February-2020 to 30-August-2020, n=2,255) periods. We examined changes in thrombolysis and endovascular therapy(EVT) rates, workflow, and in-hospital outcomes. Results: Hospitalizations/presentations for ischemic stroke dropped (weekly adjusted-incidence-rate-ratio[aIRR]:0.48, 95%CI:0.46-0.50, adjusted for age, sex, comorbidities, pre-admission care needs), as did population-level incidence of thrombolysis(aIRR:0.49,0.44-0.56) or EVT(aIRR:0.59,0.49-0.69). However, the proportions of presenting patients receiving acute therapies did not decline (e.g. thrombolysis:11.7% pre-pandemic vs 13.1% during-pandemic, aOR:1.02,0.75-1.38). Onset-to-door times were prolonged; EVT recipients experienced longer door-to-reperfusion times (median door-to-reperfusion:110-minutes, IQR:77-156 pre-pandemic vs 132.5-minutes, 99-179 during-pandemic; adjusted-coefficient:18.7-minutes, 95%CI:1.45-36.0). Hospitalizations were shorter but stroke severity and in-hospital mortality did not differ. Interpretation: The first COVID-19 wave was associated with a halving of presentations and acute therapy utilization for ischemic stroke at a population level, and greater pre-hospital and in-hospital treatment delays. Our data can inform public health messaging and stroke care in current and future waves. Messaging should encourage attendance for emergencies and stroke systems should re-examine code stroke protocols to mitigate inefficiencies.

contracting COVID-19 are at high cardiovascular risk, like older people or those with heart disease who were specifically warned of being at higher risk of severe COVID-19 in some public health messaging. 3 Social distancing may also result in loss of services and support networks for seniors or patients with disabilities, potentially impairing their ability to seek medical assistance. 4 Furthermore, pandemics generate additional challenges of managing personal protective equipment.(PPE) and cleaning protocols, 5 and additional information bottlenecks, all of which could result in pre-hospital and in-hospital workflow delays for emergencies like stroke. 6 There are preliminary reports of a decline in patients presenting to hospital with acute stroke or ACS. 7, 8 A World Stroke Organization survey of members in multiple countries indicated a sharp reduction in acute stroke admissions by up to 50-80% in the first few weeks of the pandemic. 9 An international cross-sectional study reported a global decline in stroke hospitalizations. 10 These reports are especially troubling because recent viral or respiratory infections are known to double the risk of stroke and ACS, 11 suggesting we should be seeing more, not fewer, of these presentations. There is also some indication that those patients who do present are doing so later than usual, perhaps because they are waiting until their condition becomes more severe or intolerable. 12, 13 Two small studies from Hong Kong reported delays in presentation for patients with stroke and ACS seen during the COVID-19 pandemic compared to the year before. 14, 15 Verifying and quantifying the effect of the pandemic on stroke presentations and workflow can help us better tailor our public health messaging to continue emphasizing the time-critical nature of emergencies like stroke. Such data may also help us optimize our pandemic stroke workflow protocols, or at least adjust our expectations for what can be accomplished under such exceptionally challenging circumstances. We undertook a population study of changes in hospitalizations, treatment rates, presentation delays, and workflow delays for ischemic stroke during the first wave of the COVID-19 pandemic in the province of Alberta, Canada. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. In addition, we extracted data on use of thrombolysis and endovascular therapy.(EVT) through the QuICR program, which includes two comprehensive stroke centres.(the.sole.providers.of.EVT) and 15 urban and remote hospitals designated as Alberta's primary stroke centres, which can provide thrombolysis. No other centres provide hyperacute stroke care. The QuICR registry, released in January 2016, collects key data for all patients receiving thrombolysis and/or EVT.(details.at https://cumming.ucalgary.ca/research/quicr/home). It is managed by stroke co-ordinators at each of the 17 stroke centres. Quality control measures are taken quarterly; the data are comprehensively validated against electronic medical records. We abstracted patient demographics; stroke severity (National.Institutes.of.Health.Stroke.Scale.score.[NIHSS]); pre-hospital workflow (times for stroke onset, call to emergency medical services, ambulance dispatch, paramedics-on-scene, hospital arrival); and in-hospital workflow or treatment-related metrics (CT, thrombolysis, EVT groin puncture and reperfusion times). These data were linked using the patients' provincial healthcare number.

The study was approved by the University of Calgary Conjoint Health Research Ethics Board.(REB20-0769). No informed consent was required.

Based on our sample size calculations.(Supplement), we needed at least 38 treated patients in the Pandemic period to achieve 80% power for identifying a 25% drop in treatment volume or times. By 30-August-2020, we had already accrued 408 patients in QuICR during the pandemic, so we proceeded with our analyses. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Alberta's first COVID-19 case was identified on 28-February-2020. 20 In March, the Government of Alberta declared a state of emergency under the Public Health Act and imposed measures limiting gatherings to 15 people, prohibiting and/or limiting attendance at public and private facilities. Daycares were closed, educational institutions switched to online learning, and companies switched to workfrom-home arrangements whenever possible. All "close-contact" health and personal care services were closed, and scheduled non-urgent and elective surgeries were postponed. 21 Therefore, the "Pandemic period" for this study was defined as 28-February-2020 to 30-August-2020.(inclusive)

whereas the "Pre-Pandemic period" was defined as 1-January-2016 to 27-February-2020.

For the primary analyses, we compared the rate of patients presenting to emergency departments with stroke and the rate of thrombolysis/EVT for stroke (as cases over time) in the Pre-Pandemic and Pandemic periods using Poisson regression, adjusted for age, sex, continuing care needs, and (for thrombolysis/EVT) NIHSS and onset-to-door time. The decision to pursue this pre-and post-analysis -as opposed to various potential methods like interrupted time series, other segmented regression modelling, or restricting the pre-pandemic period to certain months -was made based on published provincial stroke data, which have shown that there is no seasonality to stroke admissions in Alberta. 22 For the incidence rate ratio calculation in the Poisson regressions, we defined time epochs as weeks (e.g. stroke hospitalizations/presentations per week for Pandemic vs Pre-Pandemic periods), and then verified our findings using monthly and quarterly time epochs as well.

For secondary analyses of pre-hospital factors, we compared the proportions of all stroke patients who received thrombolysis/EVT in the Pandemic vs Pre-Pandemic periods using (a).Fisher's exact and (b).logistic regression adjusted for age, NIHSS, and onset-to-door time. As EVT utilization was expected to increase over the study period given expanding awareness and indications, particularly with the publication of late-window trials in 2018, 23 we performed a sensitivity analysis restricting the Pre-Pandemic comparison period to 1-January-2018 onwards. We used similar logistic regressions for in-hospital mortality. We also compared pre-and in-hospital workflow times and hospital length-of-stay using (a).Wilcoxon rank sum and (b).generalized linear models (GLM) adjusted for age, sex, preadmission continuing care needs, comorbidities, and NIHSS. We compared the NIHSS on admission in the Pandemic vs Pre-Pandemic periods using Wilcoxon rank sum and GLM adjusted for age, sex, comorbidities, and continuing care needs.

Analyses of incidence and onset-to-call/door times were stratified by age (≥65-years vs <65-years) and pre-admission continuing care needs (any vs none) after testing for heterogeneity of effects, as we were particularly interested if there were differences among these groups. All analyses were performed with STATA/MP 16.1. Statistical significance was defined as p<0.05. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Hospitalizations/presentations for ischemic stroke dropped in the Pandemic period, whether using weekly, monthly, or quarterly epochs. (Figure. 1,. Table. 2). There was no interaction by age (pinteraction:0.48), pre-admission continuing care needs (p-interaction:0.63), or minor stroke diagnoses (vs major stroke, p-interaction:0.41). There were similar declines in the incidence of thrombolysis and EVT, compared to the somewhat stable overall incidence of thrombolysis prepandemic.( Figure. 2A) and the previously rising utilization of EVT. (Figure. 2B,. Table. 2).

However, the proportions of patients presenting with an ischemic stroke receiving thrombolysis and EVT did not decline during the first wave.( Onset-to-door times could be calculated for all 3,048 treated patients with out-of-hospital ischemic stroke, and were prolonged during the pandemic. (Table. 3). This effect was not modified by age or continuing care needs. Among 2,532(98.6%) thrombolysis recipients and 1,146(92.4%) EVT recipients, there were no significant differences in door-to-CT or door-to-needle times, but CT-to-groinpuncture, door-to-groin-puncture, groin-puncture-to-reperfusion, and door-to-reperfusion times for EVT were prolonged post-COVID-19. (Table. 3). Differences in door/CT-to-groin-puncture times were attenuated on adjusted GLM, but delays in groin-puncture-to-reperfusion and door-to-reperfusion remained significant. (Table. 3).

Among patients treated with thrombolysis or EVT, there were no differences in NIHSS scores at baseline on unadjusted analyses. (Table. 3). For modelling analyses, we imputed the baseline NIHSS for 33 patients using the 24-hour.NIHSS score. There was a slightly lower NIHSS among treated All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Using the population of an entire Canadian province, we found that the first wave of the COVID-19 pandemic was associated with a marked decline in hospital presentations for ischemic stroke and in the absolute utilization of acute stroke therapies including thrombolysis and EVT. There were greater delays in hospital presentation and in both pre-hospital and in-hospital workflow.

We have validated concerns raised by different groups from survey data about the pandemic's indirect effects on medical emergencies. 24,25 Declines on the order of 40% or greater in ACS and stroke admissions were reported from surveys of Spanish centres. 26,27 A cross-sectional study from the United States found that ACS hospitalizations decreased by about 19 cases/week, with a rise in riskadjusted mortality. 13 Preliminary reports on stroke care included a 25% relative drop in stroke admissions and 14% drop in thrombolysis among Italian stroke units in March 2020 versus March 2019. 8 We have now shown that the pandemic was associated with a similar magnitude of decline in presentations for ischemic stroke and use of acute therapies, even after adjusting for relevant variables and including/excluding minor stroke. It is unlikely that the drop reflects a true decline in stroke occurrence, and we suspect that it reflects pandemic-related hospital avoidance, as also indicated by a recent population-based study showing fewer abdominal and gynecological emergency department visits in Ontario during the pandemic. 28 Importantly, the diminished utilization of thrombolysis/EVT reflected the decline in stroke presentations rather than any therapeutic inertia: the proportion of presenting patients receiving thrombolysis was unchanged and that receiving EVT increased over the study period, reflecting pre-pandemic trends.

Pre-hospital delays in onset-to-door times confirm that patients who presented with acute stroke during the first wave tended to present later than usual. Observed delays are in keeping with prior small.studies.reporting.delayed.stroke.and.ACS.presentations. 14 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.04.21264529 doi: medRxiv preprint Workflow delays at both the pre-hospital and in-hospital stages (particularly for EVT) reflect the procedural changes necessary for pandemic care (use of PPE for all staff, enhanced cleaning protocols for imaging equipment and procedure rooms, etc). Preliminary data on such delays have come from different parts of the world for ACS 13, 31 and acute stroke, 32 

Canadian study which reported longer onset-to-door, door-to-needle, and door-to-reperfusion times. 33 Whereas some delays may be inevitable under such challenging circumstances, our population data should serve as a call to action for stroke systems to closely re-examine their pandemic protocols to mitigate workflow inefficiencies wherever possible.

Whereas a key strength of our study is that the data arise from an entire population with a coordinated and robust stroke system of care, a few limitations merit discussion. First, we cannot know to what extent observed delays or declines in presentations were related to difficulties calling for help or accessing medical services, versus pure hospital avoidance. Second, because the cohort was defined by ICD administrative data, strokes may have been misclassified in some cases; however, our data sources and case definitions have been validated in prior audits. 18 Third, data on pre-hospital and inhospital workflow were only available for patients who received acute stroke therapies, likely resulting in underestimation of delays, since patients presenting much later would be less likely to receive therapies like thrombolysis. Whereas both hospitals and paramedics adopted additional infection prevention precautions, we do not have specific data on why delays occurred in different settings.

Fourth, we do not have longer-term outcome data on most patients in the pandemic era, so we could not assess downstream effects of observed delays; however, post-stroke outcomes are highly dependent on time-to-treatment. 34 Fifth, our dataset did not contain the COVID-19 status of patients, so we do not know whether patients were managed differently based on their infectious state; however, all patients were managed as potentially infectious in the first 24-hours pending RT-PCR results. Furthermore, rates of COVID-19 in Alberta were very low during the first wave, with about 14,000 cases or 0.35% of the population affected; 20 thus, this is almost purely a study of the effects of public health measures, patient avoidance, and hospital infection prevention measures, in the absence of major strains on emergency medical services or hospitals from large numbers of infected patients.

In conclusion, the first wave of the COVID-19 pandemic in Alberta was associated with a halving of presentations for ischemic stroke and use of acute therapies at a population level, and greater prehospital and in-hospital workflow delays, but in those patients who did present, the provision of thrombolysis/EVT was similar to pre-pandemic levels. Given our findings, there seems little doubt that the cerebrovascular implications of the COVID-19 pandemic will extend beyond just direct infectionrelated damage in survivors. Public health messaging in future waves should encourage hospital attendance for acute conditions like stroke rather than blanket stay-at-home statements. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.04.21264529 doi: medRxiv preprint 1 0 CONTRIBUTORS AG conceived and co-designed the study, secured funding, performed statistical analysis and interpretation, and wrote and revised the manuscript. JMS collected data for the study and contributed to the analysis. FAM co-designed the study, provided resources for data collection, and contributed to both data interpretation and manuscript revision. OS, JKH, and BM helped design the study and provided critical revision of the manuscript. MDH and EES co-designed the study, provided study supervision and funding, interpreted data, and revised the manuscript.

The study was funded by the Canadian Cardiovascular Society (CCS) through the COVID-19

Challenge for Canada Initiative (CCS-C3I). (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.04.21264529 doi: medRxiv preprint 1 5 Table 1 . Key demographic and clinical characteristics of patients presenting or hospitalized with ischemic stroke in the Pre-COVID-19-Pandemic (1-January-2016 to 27-February-2020) and

Pandemic periods (28-February-2020 to 30-August-2020) in Alberta, Canada.

Pre-Pandemic period Pandemic period

Entire study population N=19,531 N=2,255 1 6 

Avoidance behaviors and negative psychological responses in the general population in the initial stage of the H1N1 pandemic in Hong Kong

The impact of the SARS epidemic on the utilization of medical services: SARS and the fear of SARS

Covid-19: Highest risk patients are asked to stay at home for 12 weeks

Public Health Responses to COVID-19: Whose Lives Do We Flatten Along With "The Curve

Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic

Ignorance is not bliss: managing uncertainty in acute stroke treatment in the COVID-19 era

Admissions to Veterans Affairs Hospitals for Emergency Conditions During the COVID-19 Pandemic

Reduced Admissions for Cerebrovascular Events During COVID-19 Outbreak in Italy

COVID-19 and stroke-A global World Stroke Organization perspective

Global Impact of COVID-19 on Stroke Care and Intravenous Thrombolysis

Physical, psychological and chemical triggers of acute cardiovascular events: preventive strategies

Decrease and Delay in Hospitalization for Acute Coronary Syndromes During the 2020 SARS-CoV-2 Pandemic

Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease

Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong

No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted

Out-of-hospital cardiac arrest during the COVID-19 pandemic

Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial Infarction Presentations and In-Hospital Outcomes

Break in the Stroke Chain of Survival due to COVID-19

Early Impact of the COVID-19

Minor stroke (non-hospitalized

All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.04.21264529 doi: medRxiv preprint All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.04.21264529 doi: medRxiv preprint 1 7 Table 3 . Pre-hospital and in-hospital factors and stroke severity of patients with ischemic stroke who received acute stroke therapies in the Pre-COVID-19-Pandemic (1-January-2016 to 27-February-2020) and Pandemic periods (28-February-2020 to 30-August-2020) in Alberta, Canada. Significant differences (p<0.05) for hypotheses testing are indicated with an asterisk (*). Generalized Linear Models (GLMs) were adjusted for age, sex, pre-admission continuing care needs, comorbidities, and (for all except NIHSS analyses) the baseline NIHSS.

Pre-Pandemic period The adjusted coefficients presented are a comparison of the given parameter for the Pandemic vs Pre-Pandemic Period after adjusting for relevant factors. For example, this means that onset-to-door times were on average 37.0 minutes longer in the Pandemic period. All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.04.21264529 doi: medRxiv preprint 1 8 All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.04.21264529 doi: medRxiv preprint All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.